MedTech Synergy Hydrix's core strength in regulated medical devices and life critical systems, together with Echo IQ's distribution network in Australia, New Zealand and Singapore, creates a ready opportunity for collaborative selling of engineering, regulatory and manufacturing services to medical device makers seeking faster time to market.

APAC Expansion Hydrix already has APAC reach through Echo IQ and its focus on cardiac and surgical devices such as LUDO, making it well positioned to pursue new hospitals, device manufacturers and contract manufacturing partners across Australia, New Zealand and Singapore. Leverage partnerships to cross sell platform technologies and regulatory advisory services.

Defence Growth Hydrix's capabilities in defence systems, autonomous platforms, embedded software and safety critical hardware position it to win government and defence supplier contracts requiring complex systems engineering, certification and compliance. Pursue program based bids and partnerships with sovereign technology programs.

Platform Differentiation Hydrix's LUDO platform for mechanical circulatory support development and the EchoSolv distribution network illustrate a platform led approach that speeds product development. Sales opportunities include platform licensing, services access, integration projects, and expansion into related medical and defence devices.

Regulatory Advantage Hydrix has a track record in medical device regulatory consulting combined with hands on design and testing capabilities, enabling end to end regulatory, quality management and post market surveillance services. Target early stage medtech startups and established manufacturers expanding into Australia, New Zealand and Singapore.